Hovione
Jerod Robertson possesses extensive experience in the pharmaceutical industry, currently serving as Principal Scientist at Hovione. Prior roles include Associate Director of API Technology Portfolio Management at Merck and Head of Process Chemistry at Hovione. Jerod's earlier experience at AMRI involved progressive roles from Senior Research Scientist I to Senior Research Scientist III. Educational qualifications include a PhD in Organic Chemistry from the University of Reading and a Post-doctorate in Synthetic Organic Chemistry from the University of Nottingham.
Hovione
2 followers
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.